# A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green

> **NCT06768268** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **National Taiwan University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer Early Stage Breast Cancer (Stage 1-3)

## Interventions

- **PROCEDURE:** Voluven-assisted Indocyanine green fluorescence guided sentinel lymph node biopsy for breast cancer
- **DRUG:** Mannitol (20%)

## Key facts

- **NCT ID:** NCT06768268
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06768268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06768268, "A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06768268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*